148 related articles for article (PubMed ID: 22822082)
1. Oxidation-mediated DNA cross-linking contributes to the toxicity of 6-thioguanine in human cells.
Brem R; Karran P
Cancer Res; 2012 Sep; 72(18):4787-95. PubMed ID: 22822082
[TBL] [Abstract][Full Text] [Related]
2. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation.
Brem R; Daehn I; Karran P
DNA Repair (Amst); 2011 Aug; 10(8):869-76. PubMed ID: 21723207
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions.
Brem R; Li F; Karran P
Nucleic Acids Res; 2009 Apr; 37(6):1951-61. PubMed ID: 19208641
[TBL] [Abstract][Full Text] [Related]
4. Combination of azathioprine and UVA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine.
Cooke MS; Duarte TL; Cooper D; Chen J; Nandagopal S; Evans MD
DNA Repair (Amst); 2008 Dec; 7(12):1982-9. PubMed ID: 18793759
[TBL] [Abstract][Full Text] [Related]
5. Interconnections between apoptotic and autophagic pathways during thiopurine-induced toxicity in cancer cells: the role of reactive oxygen species.
Chaabane W; Appell ML
Oncotarget; 2016 Nov; 7(46):75616-75634. PubMed ID: 27689330
[TBL] [Abstract][Full Text] [Related]
6. Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letter.
de Boer NK; van Asseldonk DP; Seinen ML; van Bodegraven AA
Cancer Res; 2013 Feb; 73(4):1445. PubMed ID: 23393198
[No Abstract] [Full Text] [Related]
7. Immune effector cells produce lethal DNA damage in cells treated with a thiopurine.
Daehn I; Karran P
Cancer Res; 2009 Mar; 69(6):2393-9. PubMed ID: 19244103
[TBL] [Abstract][Full Text] [Related]
8. Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation.
Gueranger Q; Li F; Peacock M; Larnicol-Fery A; Brem R; Macpherson P; Egly JM; Karran P
J Invest Dermatol; 2014 May; 134(5):1408-1417. PubMed ID: 24284422
[TBL] [Abstract][Full Text] [Related]
9. Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light.
Zhang X; Jeffs G; Ren X; O'Donovan P; Montaner B; Perrett CM; Karran P; Xu YZ
DNA Repair (Amst); 2007 Mar; 6(3):344-54. PubMed ID: 17188583
[TBL] [Abstract][Full Text] [Related]
10. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.
Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
Carcinogenesis; 1998 Nov; 19(11):1931-7. PubMed ID: 9855005
[TBL] [Abstract][Full Text] [Related]
11. BNIP3 is essential for mediating 6-thioguanine- and 5-fluorouracil-induced autophagy following DNA mismatch repair processing.
Zeng X; Kinsella TJ
Cell Res; 2010 Jun; 20(6):665-75. PubMed ID: 20368736
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.
Hosni-Ahmed A; Barnes JD; Wan J; Jones TS
PLoS One; 2011; 6(12):e29163. PubMed ID: 22216194
[TBL] [Abstract][Full Text] [Related]
13. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.
Coulthard SA; Redfern CP; Vikingsson S; Lindqvist-Appell M; Skoglund K; Jakobsen-Falk I; Hall AG; Taylor GA; Hogarth LA
Mol Cancer Ther; 2011 Mar; 10(3):495-504. PubMed ID: 21282358
[TBL] [Abstract][Full Text] [Related]
15. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine and UVA light generate mutagenic oxidative DNA damage.
O'Donovan P; Perrett CM; Zhang X; Montaner B; Xu YZ; Harwood CA; McGregor JM; Walker SL; Hanaoka F; Karran P
Science; 2005 Sep; 309(5742):1871-4. PubMed ID: 16166520
[TBL] [Abstract][Full Text] [Related]
17. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
18. The homologous recombination protein RAD51D mediates the processing of 6-thioguanine lesions downstream of mismatch repair.
Rajesh P; Litvinchuk AV; Pittman DL; Wyatt MD
Mol Cancer Res; 2011 Feb; 9(2):206-14. PubMed ID: 21205838
[TBL] [Abstract][Full Text] [Related]
19. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.
Swann PF; Waters TR; Moulton DC; Xu YZ; Zheng Q; Edwards M; Mace R
Science; 1996 Aug; 273(5278):1109-11. PubMed ID: 8688098
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin and S6 kinase 1 positively regulate 6-thioguanine-induced autophagy.
Zeng X; Kinsella TJ
Cancer Res; 2008 Apr; 68(7):2384-90. PubMed ID: 18381446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
